Nine Masts Capital LTD Zai Lab LTD Transaction History

Nine Masts Capital LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$15.95 - $26.8 $223,300 - $375,200	14,000 New	14,000 $224,000
Q1 2020 Apr 29, 2020	SELL	$39.1 - $62.9 $281,520 - $452,880	-7,200 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$29.79 - $43.06 $214,488 - $310,032	7,200 New	7,200 $299,000
Q3 2018 Nov 16, 2018	SELL	$17.8 - $25.35 $783,200 - $1.12 Million	-44,000 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$18.0 - $25.01 $360,000 - $500,200	-20,000 Reduced 31.25%	44,000 $1.02 Million
Q4 2017 Feb 12, 2018	BUY	$21.23 - $34.09 $297,220 - $477,260	14,000 Added 28.0%	64,000 $1.36 Million
Q3 2017 Nov 13, 2017	BUY	$27.0 - $31.11 $1.35 Million - $1.56 Million	50,000	50,000 $1.35 Million

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.43B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Nine Masts Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Nine Masts Capital LTD with notifications on news.